Acurx Pharmaceuticals
ACXP
ACXP
13 hedge funds and large institutions have $3.94M invested in Acurx Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$3.13M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$321K |
| 3 |
OGC
3
One68 Global Capital
New York
|
$34.6K |
| 4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$58.3K |
| 5 |
5
BlackRock
New York
|
$50K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$45.9K |
| 2 |
BAM
2
Belpointe Asset Management
Reno,
Nevada
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$0 |
